Joinn Laboratories(China)Co.,Ltd.
603127
Rang în acțiuni
#3812
Joinn Laboratories (China) Co., Ltd. delivers a comprehensive suite of... Joinn Laboratories (China) Co., Ltd. delivers a comprehensive suite of preclinical and non-clinical services to clients across the United States, China, and other international regions. The company's business is organized into three core operational areas. Its Non-Clinical Studies Services segment focuses on drug safety assessment, drug metabolism and pharmacokinetics analysis, and pharmacology and efficacy investigations. The Clinical Trial and Related Services division offers contract research organization (CRO) support for clinical trials, co-manages Phase I clinical research units, and provides bioanalytical services. Furthermore, the Sales of Research Models segment is involved in the design, production, breeding, and distribution of various research models, including non-human primates and rodents. Beyond these offerings, Joinn Laboratories also provides investment management and cell-based assay (CBA) services. Founded in 1995, the company is headquartered in Beijing, China.
Preț acțiune
$6.82
Capitalizare de piață
$4.30B
Schimbare (1 zi)
-6.30%
Schimbare (1 an)
48.79%
Țară
CN
Tranzacționează Joinn Laboratories(China)Co.,Ltd. (603127)
Categorie
Healthcare
Raport P/S pentru Joinn Laboratories(China)Co.,Ltd. (603127)
Raport P/S la data de October 2026 TTM: 16.96
Conform celor mai recente rapoarte financiare și prețului acțiunilor Joinn Laboratories(China)Co.,Ltd., raportul P/S actual (TTM) este 16.96. La sfârșitul anului 2024, compania avea un P/S de 6.10.
Istoricul raportului P/S pentru Joinn Laboratories(China)Co.,Ltd. din 2012 până în 2026
Raport P/S la sfârșitul fiecărui an
| An | Raport P/S | Schimbă |
|---|---|---|
| 2026 (TTM) | 16.96 | 7.83% |
| 2025 | 15.73 | 157.67% |
| 2024 | 6.10 | -15.66% |
| 2023 | 7.24 | -47.54% |
| 2022 | 13.80 | -50.84% |
| 2021 | 28.06 | 29.16% |
| 2020 | 21.73 | 49.50% |
| 2019 | 14.53 | 9.31% |
| 2018 | 13.30 | 3.24% |
| 2017 | 12.88 | 181.31% |
| 2016 | 4.58 | -14.49% |
| 2015 | 5.35 | -10.22% |
| 2014 | 5.96 | -23.01% |
| 2013 | 7.75 | -30.15% |
| 2012 | 11.09 | 0.00% |
Raport P/S pentru companii similare sau competitoare
| Companie | Raport P/S | Diferență raport P/S | Țara |
|---|---|---|---|
| 5.29 | -68.79% |
US
|
|
| 6.43 | -62.11% |
US
|
|
| 21.32 | 25.68% |
US
|
|
| 6.53 | -61.51% |
CN
|
|
| 6.80 | -59.91% |
US
|
